Innovation is speeding ahead of government rules, leaving some products in a legal grey area. This can affect consumer safety since regulations haven’t caught up yet
Since the 2018 law change legalising medical cannabis in the UK, the market has emerged as a prescription-led industry with strong regulatory oversight. This framework is fostering growth by building trust among healthcare professionals and patients alike
그는 지난달 한 인터뷰에서는 “금과 은보다 비트코인(Bitcoin) 투자를 더 선호한다”면서 가상화폐 가격이 2년 이내에 개당 600만달러를 돌파할 것으로 전망하기도 했었다. 그는 순간 인터뷰에서 “나는 COVID-19로 말미암아 봉쇄조치(락다운) 덕에 비트코인(Bitcoin)을 9000달러에 샀는데, 그 때까지만 해도 바가지를 썼다고 마음했지만 오늘날 알트코인 가격을 마음해 보면 잘한 선택인 것 같다”며 만족감을 선보인 바 있다.
Since the 2018 legalisation of medical cannabis in the UK, the market has evolved into a prescription-led industry governed by strict regulation
Innovation is speeding ahead of regulation, especially with grey-area products that don’t fit neatly into existing rules. This can mean risks to consumer safety, as protections lag behind new tech or services
Innovation is racing ahead, often outpacing the rules meant to keep us safe. This means some products fall into a grey area, where it’s unclear if they meet all safety standards
Innovation often outpaces the rules meant to keep us safe, leaving some products in a grey area where regulations aren’t clear. This can put consumers at risk, as newer gadgets or services might not be fully tested
Since the 2018 legalisation of medical cannabis in the UK, the market has evolved into a tightly regulated, prescription-led industry. This framework ensures patient safety and builds trust among healthcare professionals, which is driving steady growth
Since the 2018 law change legalising medical cannabis in the UK, the market has developed as a strictly prescription-led industry
Innovation today often outpaces regulation, leaving some products in grey areas where safety rules aren’t clear. This can be worrying for consumers keen to stay safe